The Top 50 Healthcare AI Entrepreneurs of 2025

The entrepreneurs recognized in this award are at the forefront of this change, using AI to develop solutions that enhance healthcare precision and efficiency. Their work spans AI-powered diagnostics, automated patient care, drug development, and predictive health, with each leader driving meaningful advancements in their field. By pushing the boundaries of what AI can achieve, they are not only transforming healthcare but also demonstrating the profound impact that vision, dedication, and cutting-edge technology can have on improving lives.

Among this year’s awardees, Jurgi Camblong, Co-Founder and CEO of SOPHiA GENETICS, has emerged as a leader in AI-powered data analysis, driving advancements in genomic medicine and helping hospitals and biopharma organizations improve patient care through actionable insights. Connor Landgraf, Co-Founder and CEO of Eko Health, is revolutionizing cardiovascular and pulmonary disease monitoring, leveraging AI and non-invasive sensors to enhance disease detection and improve clinical outcomes worldwide. Punit Soni, Founder and CEO of Suki, is transforming healthcare administration by utilizing AI to reduce clinician burnout and streamline the administrative tasks that hinder effective patient care, making healthcare processes more efficient and accessible.

This year’s awardees were selected through a methodical process and careful consideration of each candidate’s career track record and industry contributions. Please join us in celebrating The Top 50 Healthcare AI Entrepreneurs of 2025.

 

1. Chris Gibson
Co-Founder and Chief Executive Officer, Recursion Pharmaceuticals

Chris Gibson is the Co-Founder and Chief Executive Officer of Recursion Pharmaceuticals. Recursion integrates innovations across biology, chemistry, automation, data science, and engineering to develop new approaches in drug development. The company’s technology enables the creation of learning cycles around datasets to enhance the drug discovery process. Recursion is committed to decoding complex biology to improve lives.

Gibson brings 20 years of experience to his current role. He developed the technology and approach that seeded Recursion as part of his MD/PhD work in the lab of Co-Founder Dr. Dean Li (current President of Merck Research Labs) while at the University of Utah. After completing his PhD, Gibson left medical school to build Recursion. Gibson is a graduate of Rice University with degrees in bioengineering and management. 

Gibson serves on the Board of BioHive, the public-private partnership driving expansion of Utah's life-science ecosystem. Gibson is also active as an advisor and mentor to young biotech founders. 

 

2. Jurgi Camblong
Co-Founder and Chief Executive Officer, SOPHiA GENETICS

Jurgi Camblong is the Co-Founder and Chief Executive Officer of SOPHiA GENETICS, a cloud-native healthcare technology company focused on expanding access to data-driven medicine. The company leverages AI to enhance patient care for cancer and rare disorders globally. It developed the SOPHiA DDM Platform, which analyzes complex genomic and multimodal data to generate real-time, actionable insights for hospitals, laboratories, and biopharma institutions.

Dr. Camblong holds a PhD in life sciences from the University of Geneva and an Executive MBA in management of technology from EPFL/HEC Lausanne. He is a published molecular biologist, with work featured in Cell, Science, and Nature. In 2011, he co-founded SOPHiA GENETICS with Dr. Pierre Hutter and Prof. Lars Steinmetz and has served on the Board of Directors since March 2011. 

 

3. Dave Werry
Co-Founder & President, Well

Dave Werry is the Co-Founder & President of Well, a dynamic health intervention platform and service built to address the diverse and evolving health needs of employee populations. Well’s real-time, personalized actions are served up to each individual daily, designed to address the full spectrum of population health needs, tailored to an organization's unique challenges. Well aims to redefine well-being with a whole-person approach that precisely targets dynamic health interventions and incentives with personalized engagement strategies. 

David was previously the VP of Transformation at Aetna where he oversaw the member-facing capabilities for the enterprise. These areas included Aetna’s digital assets, concierge services, Apple partnership, high-touch clinical services as well as business units in healthcare payments, benefits enrollment and population health management. 

Prior to joining Aetna, David was the Head of Biotech at PPD, a global clinical research organization. David began his career at Morgan Stanley and then Hellman & Friedman, a large private equity firm, where he focused on healthcare investing. David was a Morehead Scholar at the University of North Carolina and holds an MBA from Harvard Business School.

Dave Werry's Insight

“We believe everyone deserves access to a trusted health guide. We’ve built a platform that connects each member to the right place at the right time, regardless of what you look like, where you live or what health coverage you have or don’t have."

 

4. Punit Soni
Founder & CEO, Suki

Punit Singh Soni is the Founder and Chief Executive Officer of Suki, a leading healthcare AI company. He leads a team of physicians, engineers, and technologists creating innovative solutions to lift the administrative burden from clinicians, including the company’s flagship product, Suki Assistant. Suki also offers its proprietary AI platform, Suki Platform, to partners who want to create best-in-class AI experiences for their solutions. 

Prior to starting Suki, Punit was the Chief Product Officer of Flipkart, a $15 billion Indian e-commerce company. Punit also held leadership positions at Google including VP of Product at Motorola, Lead PM at Google+ Mobile and Google Mobile Apps, PM at News, News Archive and Search. 

Punit holds an MBA from the Wharton School and bachelor’s and master’s degrees in electrical engineering.

 

5. Andrew Miller
Co-Founder & COO, Restor3d

Dr. Miller is the Chief Operating Officer and Co-Founder of restor3d, a company specializing in personalized musculoskeletal care through the design, development, and manufacturing of next generation implants and instruments. By leveraging expertise in additive manufacturing, materials science, and AI, restor3d enables surgeons with an enhanced ability to repair and reconstruct the human body in order to restore each patient's quality of life. 

Dr. Miller initially served as CEO from the company’s founding until 2021 when he transitioned to COO. As an early leader he spearheaded the development of many of the business's core processes to deliver on the company’s promise of providing high quality implants and instruments at industry leading speed.

Previously, Dr. Miller served as an adjunct professor at Duke University, where he developed and delivered a graduate engineering course on 3D printing, giving him a broad understanding of the technology and industry. He holds bachelor’s and master’s degrees in civil/structural engineering, as well as a PhD in bioengineering from Georgia Tech.

 

6. Connor Landgraf
Co-Founder and Chief Executive Officer, Eko Health

Connor Landgraf is Co-Founder and Chief Executive Officer of Eko Health. Landgraf founded Eko Health while studying bioengineering at the University of California, Berkeley, with the goal of improving cardiovascular and pulmonary disease monitoring through machine learning and non-invasive sensors. 

Eko Health became the youngest team to receive FDA clearance for a medical device. Its technology is used by hundreds of thousands of clinicians to screen millions of patients around the world more effectively for cardiac and pulmonary disease, both in person and through telehealth. Since its founding, Eko Health has built the world’s largest database for heart sounds and is making advanced disease detection capabilities available for clinicians.

 

7. Shyam Rajagopalan
Co-Founder and Technology Lead, Infinitus Systems

Shyam Rajagopalan is the Co-Founder and CTO of Infinitus. As an experienced and hands-on leader, Rajagopalan actively collaborates with his team, contributing to coding and providing guidance on technical and product design.

Infinitus is solving healthcare's workforce challenges with safety-first AI. By automating clinical and administrative tasks with voice AI agents, Infinitus helps alleviate staff burden and improve patient outcomes at scale. Today, the company supports 44% of the Fortune 50, and has impacted the work of more than 125,000 healthcare providers.

Prior to Infinitus, as a software architect, Rajagopalan designed, built, and launched highly secure, high throughput systems for Snap Inc. and Google's login and security platforms. He previously led the engineering team as Director of Engineering at the mobile intelligence startup Quettra (acquired by Similar Web). Rajagopalan began his career at MIPS and Nvidia, designing and building high performance CPUs.

 

8. Wael Salloum
Founder and Chief Science Officer, Mendel.ai

Dr. Wael Salloum is the Founder and Chief Science Officer of Mendel.ai, a San Jose-based clinical artificial intelligence platform that enhances clinical data workflows by integrating large language models with a proprietary clinical hypergraph. This approach delivers scalable clinical reasoning without hallucinations and ensures 100% explainability. 

Under Dr. Salloum's leadership, Mendel.ai has secured significant investments, including a $40 million Series B funding round in April 2022, led by Oak HC/FT with participation from existing investor DCM. Dr. Salloum built innovative products at Mendel.ai like Resolve, which performs longitudinal reasoning on a patient’s medical record to construct a coherent and comprehensive journey, and Hypercube, which allows large-scale reasoning over massive knowledge bases of patient records. 

Before founding Mendel.ai, Dr. Salloum was a Founding Member and Senior Research Scientist at EMR.AI, developing novel speech/NLP solutions for medical documentation, and a Founder and CSO of MedTools.com, building knowledge bases and reasoning search engines for the medical device industry. 

Dr. Salloum holds a PhD in computer science from Columbia University, where his research focused on machine translation and natural language processing.

 

9. Sina Chehrazi
Founder & CEO, Nayya

Sina Chehrazi is the Co-Founder and Chief Executive Officer of Nayya, a company focused on transforming how employees navigate health and wealth decisions. Founded in 2019, Nayya connects people’s key information to simplify and enhance the benefits experience, turning complex processes into seamless, intuitive, and continuous interactions, powered by AI for real-world impact.

A leader at the intersection of technology, insurance, and healthcare, Sina has dedicated his career to making benefits smarter, simpler, and more accessible. Before founding Nayya, he worked in strategic partnerships and business development, helping companies leverage data and technology to drive better outcomes.

Sina holds a bachelor’s degree in business administration and a JD from Georgetown University.

 

10. Eric Litman
Founder and Chief Executive Officer, Aescape

Eric Litman is the Founder and Chief Executive Officer of Aescape. He is a prolific entrepreneur with four successful exits, leading innovation at the intersection of technology and human care.

Aescape emerged from stealth last year after seven years of intensive R&D, built by a team of alumni from Amazon, Apple, Fitbit, MakerBot, Peloton, Tonal, and more. The company’s automated massage technology leverages advanced AI to build a 3D computational model of each user, delivering a personalized experience uniquely tailored to their body. With plans to expand into hospitality, professional sports, corporate offices, and luxury real estate, Aescape aims to reshape wellness on a global scale.

 

11. Doktor Gurson
Co-Founder and Chief Executive Officer, Rad AI

Doktor Gurson is the Co-Founder and Chief Executive Officer of Rad AI. He is an experienced entrepreneur with a strong passion for technology and innovation. His journey began as a teenager when he founded one of the world’s first ICANN-accredited domain registrars.

Under his leadership, Rad AI is transforming radiology workflows by partnering with over half of all radiology providers in the United States, including nine of the ten largest radiology groups. The company’s proprietary, purpose-built AI solutions help reduce burnout, enhance efficiency, and improve patient care.

In addition to his work at Rad AI, Doktor invests in promising startups, providing them with strategic guidance and mentorship to help them reach their full potential.

 

12. Hamid Tabatabaie
Founder, Chief Executive Officer and President, CodaMetrix

Hamid Tabatabaie is the Founder, Chief Executive Officer and President of CodaMetrix. CodaMetrix provides an AI-powered platform for multi-specialty medical coding in the $20 billion annual market. The platform is used by more than a dozen leading provider organizations and health systems, covering over 200 hospitals and 50,000 providers.

Tabatabaie brings 41 years of experience to his current role. Before joining CodaMetrix, he served as CEO at lifeIMAGE and before that CEO at Amicas. Earlier in his career he worked with Data General Corporation as a director of the healthcare division. Tabatabaie graduated from Boston University with an undergraduate degree in engineering.

Hamid Tabatabaie's Insight

“This recognition reflects the dedication of our team and our shared mission to harness AI for meaningful change in healthcare. I’m honored to lead this work and excited for the continued impact we can make together.”

 

13. Sumit Nagpal
Chairman, Chief Executive Officer and Founder, Cherish Health

Sumit Nagpal is the Founder, Chief Executive Officer, and Chairman of Cherish Health. A serial entrepreneur, Sumit has focused on digital health innovation at scale, co-founding and growing five companies over the past three decades to address pressing challenges in healthcare economies.

His work consistently emphasizes bold vision, disruptive technological innovation, user-friendly experiences, and practical business models. These themes have shaped Sumit's career, starting with his time working with Steve Jobs and NeXT in the early 1990s.

 

14. Dimitrios Skaltsas
Co-Founder and Chief Executive Officer, Intelligencia AI

As the CEO and Co-Founder of Intelligencia AI, Dimitrios Skaltsas leads the AI-driven technology organization's business and investment growth strategy while overseeing critical functional areas of the multidisciplinary global team. Founded in 2017, Intelligencia AI leverages proprietary data, biomedical expertise and AI with its patented technology to address significant challenges in the pharmaceutical industry. 

Intelligencia’s suite of AI-powered solutions delivers actionable insights crucial in mitigating risks and enhancing decision-making associated with drug development by providing an accurate, unbiased assessment of a drug’s probability of success. Dimitrios played an instrumental role in forging a strategic partnership with ZS, a global professional services company.

Intelligencia was recognized by The Healthcare Technology Report as one of the Top 100 Healthcare Technology Companies. In 2024, the company received a U.S. patent for its accurate and transparent probability of drug success assessments. Before co-founding Intelligencia AI, Dimitrios spent over a decade in various healthcare and life sciences leadership roles.

Dimitrios holds an MBA from INSEAD and a law degree from University College London (UCL) and the University of Athens. 

Dimitrios Skaltsas's Insight

“I am honored by this recognition. It comes as Intelligencia AI is establishing itself as a leader in AI-driven applications and data solutions to accelerate drug development. I feel fortunate to build a company with impact and purpose that has been partnering with some of the largest pharmaceutical companies and attracting exceptional talent.”

 

15. Vijay Sikka
Chairman, Founder and Chief Executive Officer, sikka.ai

Vijay Sikka is the Founder, Chief Executive Officer, and Chairman of Sikka.ai. The company provides an AI-API platform that serves the $1 trillion dental, veterinary, optometry, and retail healthcare markets. Sikka.ai has 150 million patients on its platform, with 40,000 practices and a broad customer base, including 18 hedge funds, major manufacturers, financial institutions, five life insurance companies, and 50 software companies. The platform adds 15-20 new practices daily and is EBITDA positive, with 90% recurring revenue and rapid growth.

Vijay holds a master’s degree in electrical engineering and AI from Syracuse and has completed PhD work in AI and neuroscience at Stanford. While he did not complete his PhD, his research on self-supervised learning has been published in major AI conferences, including IJCNN, IJCAI, AAAI, IEEE, SPIE, CHMT, and NeurIPS precursor.

Vijay led the Fabs AI group at Intel Corporation in the mid-90s before founding his first company, which was acquired after competing with Informatica, Hyperion, and Cognos. His second company was also acquired in 2002.

 

16. Guy Benjamin
Co-Founder and Chief Executive Officer, Healthee

Guy Benjamin, Chief Executive Officer and Co-Founder of Healthee, is redefining digital healthcare by leveraging AI to simplify how employees engage with their health benefits. With a mission to bring transparency and accessibility to benefits navigation, Guy has propelled Healthee into a trusted partner for over 15,000 companies. His leadership has not only streamlined benefits administration but also delivered significant time and cost savings while improving health outcomes for employees.

In 2024, Guy’s vision led to transformative partnerships with industry giants like TriNet and Blackhawk, further expanding Healthee’s footprint. The company also secured $32 million in Series A funding to enhance its AI-powered platform, which now boasts innovative features such as advanced plan comparison algorithms and real-time cost transparency tools.

 

17. Eric Kelsic
Co-Founder and Chief Executive Officer, Dyno Therapeutics

Eric Kelsic is the Co-Founder and Chief Executive Officer of Dyno Therapeutics, a company pioneering an AI-powered approach to gene therapy. Dyno uses machine learning and high-throughput in vivo experimentation to design gene vectors, focusing on cell-targeting capsid proteins from adeno-associated virus (AAV), the most widely used vector for gene therapies. The team includes experts in molecular and synthetic biology, protein engineering, gene therapy, software engineering, data science, and AI, working together to advance the field.

Kelsic brings 17 years of experience to his current role. Before joining Dyno Therapeutics, he was a staff scientist at Wyss Institute at Harvard University and before that a postdoctoral research fellow at Harvard Medical School. Earlier in his career he worked as a researcher and technician in chemical engineering at Caltech.

Kelsic graduated from Harvard University with a PhD in systems engineering and from Caltech with an undergraduate degree in physics.

 

18. Coleman Stavish
Co-founder & CTO, Proscia

Coleman Stavish is the Co-Founder and Chief Technology Officer of Proscia, a company accelerating pathology’s transition to a data-driven discipline and enabling AI to advance precision medicine. Proscia's solutions fuel the development and use of novel therapies and diagnostics to drive the fight against challenging diseases.

In his role, Stavish leads a team of engineers and scientists who develop Proscia’s software and AI. The company counts 14 of the top 20 pharmaceutical companies and a global network of diagnostic laboratories among its user base and saw its growth more than double last year.

Stavish co-founded Proscia in 2014 and holds a bachelor’s degree in computer science from the University of Pittsburgh.

 

19. George Netscher
Founder and Chief Executive Officer, Safely You

George Netscher is Founder and Chief Executive Officer of SafelyYou, a company he created in 2016 after his family’s own experience with Alzheimer’s disease. SafelyYou was spun out of his research in the computer science PhD program at the UC Berkeley Artificial Intelligence Research Lab, where George was focused on using new tools in AI to aid those with cognitive impairment. From his work, he created an ambient care platform to reduce falls for memory care residents in senior living communities.

Today, SafelyYou has revolutionized care in senior living, supporting hundreds of senior living communities and thousands of residents across care levels throughout North America. Its unique combination of AI and remote clinical support is proven to reduce falls by 40% and fall-related ER visits by 80%, creating safer environments for seniors while elevating the care they’re offered. It’s also proven to extend resident length of stay by four months or more on average.

 

20. Lior Kuyer
Co-Founder and Chief Executive Officer, SignalPET

Lior Kuyer is the Co-Founder and Chief Executive Officer of SignalPET. Driven by curiosity and adaptability, Lior constantly identifies gaps and challenges conventional norms. He views entrepreneurship as a balance of risk and freedom, where sacrifice, persistence, and a focus on results are key. He believes in the power of collaboration, emphasizing that collective effort leads to greater impact.

With a strong academic foundation from the University of Amsterdam, where he earned bachelor’s and master’s degrees in artificial intelligence, Lior combines strategic vision with advanced technological expertise. Under his leadership, SignalPET continues to lead in veterinary innovation, developing tools that empower veterinarians to enhance pet healthcare. Lior’s ultimate goal is to unlock the potential of medical technology and shape the future of pet healthcare.

 

21. Cameron Andrews
Founder and President, Sirona Medical

Cameron Andrews is the Founder and President of Sirona Medical, a company dedicated to accelerating the transition to AI-powered healthcare. Sirona focuses on rebuilding outdated software systems to enable AI-driven advancements in clinical medicine, particularly in radiology, which has been a leader in AI adoption.

When Andrews founded Sirona, raising capital for AI-driven software in medical imaging was a challenge, despite over $4 billion invested in the field. The company’s team of 60 individuals spent five years and $100 million developing technology that is now setting a new standard for radiology. Sirona’s success is driven by its employees, and Andrews’ leadership has centered on fostering an environment that empowers them to achieve ambitious goals in transforming healthcare.

 

22. Eli Ben-Joseph
Co-Founder and Chief Executive Officer, Regard

Eli Ben-Joseph is the Co-Founder and Chief Executive Officer of Regard, a leading clinical insights platform working with hundreds of hospitals across the country in an effort to close the clinical insights gap. The concept for Regard was born at Stanford while Eli was a graduate student, alongside his co-founders Nate Wilson and Thomas Moulia. All three founders were on the pre-med track when they saw the unprecedented challenges that doctors were facing and embarked on their journey to bring back the heart of medicine.

Eli holds a bachelor’s degree in bioengineering and biology from MIT and a master’s degree in computer science and management from Stanford University. Prior to Regard, he worked at the MIT Media Lab on special projects.

 

23. Dexter Ang
Executive Chairman and Co-Founder, Pison

Dexter Ang is the Executive Chairman and Co-Founder of Pison, a human performance company that optimizes cognitive and physiological capability through gesture control. The company offers non-invasive electroneurography (ENG) algorithms, along with a newly developed sensor array, enabling transformative applications in cognitive enhancement, disease diagnosis and management, and overall quality of life.

Ang brings 20 years of experience to his current role and first got his start in 2005 as a senior trader at Jump Trading, his most recent position prior to joining Pison. Ang graduated from the Massachusetts Institute of Technology with an undergraduate degree in mechanical engineering.

Dexter Ang's Insight

"Innovation is being willing to ask questions and not keep them to yourself. The mark of any entrepreneur (Healthcare AI included) could be pulling on those threads and asking, 'So, what do I do about it, and how will it help society?' The implications of connecting the human body with digital systems and artificial intelligence are unimaginable. We’re in the very early innings — maybe the first inning — of what neural interfaces are going to be and how they are going to transform everything in the world.”

 

24. Ryan Fukushima
CEO and Co-Founder, Pathos

Ryan Fukushima is the Chief Executive Officer and Co-Founder of Pathos, a company focused on developing precision oncology therapeutics through a data-driven, pathway-based approach. Pathos licenses or co-develops clinical-stage drugs for patients with significant unmet needs, optimizing patient selection strategies for faster approval and improved outcomes. The company’s ultimate goal is to accelerate real-world data translation into breakthrough therapies.

As Co-Founder and CEO, Fukushima is driving innovation in drug development with artificial intelligence. In just three years, Pathos has secured over $100M in funding and developed a causal AI platform to enhance patient selection and clinical trial success rates. Under his leadership, Pathos is reshaping the drug development process.

Fukushima is a seasoned entrepreneur with experience in healthcare AI. As the first employee and second-in-command at Tempus, he played a key role in scaling the company through its IPO, building one of the world’s largest multi-modal healthcare datasets, and commercializing solutions used by thousands of physicians and biopharma companies.

Fukushima started his work experience as a Senior Associate at Hyde Park Venture Partners. He then worked as a VC and EIR at Lightbank, where he led investments in enterprise software and marketplace companies. Fukushima later joined Tempus as the Chief Operating Officer, contributing to the advancement of precision medicine through the practical application of artificial intelligence in healthcare. 

Fukushima holds a bachelor’s degree in engineering from California Polytechnic State University-San Luis Obispo and an MBA from the University of Michigan. 

 

25. Paxton Maeder-York
Founder, Alife

Paxton Maeder-York is the Founder of Alife Health, a fertility technology company building artificial intelligence tools to advance in-vitro fertilization (IVF). In 2020, Paxton started Alife Health with the mission of building a modern operating system for IVF, powered by artificial intelligence, to improve success rates and the scale of care delivery. 

Alife Health’s technology empowers reproductive endocrinologists and fertility patients to make the best clinical decisions possible through advanced analytics delivered in a medical-grade software ecosystem. 

Prior to Alife, Paxton worked on AI powered industrial robotics at Google X and was the first product manager at Auris Health, where he helped develop a surgical robotics platform to detect and treat early stage lung cancer. 

Paxton received his bachelor’s degree in biomedical engineering, master’s degree in computational science, and MBA from Harvard University. 

 

26. Enhao Gong
Founder & CEO, Subtle Medical

Enhao Gong is the Founder and CEO of Subtle Medical, a leading global provider of AI-powered technology for faster, safer, and smarter medical imaging. Enhao’s passion and research focuses on applying AI and deep learning to improve the reconstruction, analysis and quantification of medical imaging.

Gong first got his start as Co-Founder of Polarr, his most recent position prior to joining Subtle Medical. Gong graduated from Stanford University with a PhD in electrical engineering, from Stanford University with a master's degree in electrical engineering, and from Tsinghua University with an undergraduate degree in biomedical and medical engineering.

Enhao Gong's Insight

“Entrepreneurship is about turning bold visions into real-world impact. It’s not just about new technologies; it’s about creating solutions that truly make a difference in people’s lives. For me, it’s the journey of using AI to redefine what’s possible in healthcare.”

 

27. Sudha Meghan
Co-Founder and Chief Executive Officer, RozieAI

Sudha Meghan is the Managing Director of Hummingbird Health, a public health initiative focused on improving continuity of care and health disparities through digital health technology and process innovation. Hummingbird partners with community health clinics, non-profits, and health departments to deliver quality improvement across healthcare operations and public health education. 

Dr. Meghan also co-founded RozieAI and has served as the President and CEO. RozieAI is a customer experience platform focused on understanding language and context to create advanced healthcare engagement. The platform aims to serve stakeholders across the care journey—patients, healthcare providers, social workers, and care navigators.

Dr. Meghan’s focus on applying AI and digital health has been on scaling operations to serve medical deserts and weaving technology with local community dynamics and culture. Her research has been focused on behavioral economics and choice behavior and applications for healthcare access and health literacy. Dr. Meghan is passionate about Indigenous and rural healthcare access and applying AI for health justice. 

Dr. Meghan graduated from the Vagelos Life Sciences and Management Program at the College of Art and Sciences and the Wharton School of Business at the University of Pennsylvania, and earned her medical degree at the University of North Carolina School of Medicine. 

 

28. Dipanwita Das
Co-Founder and Chief Executive Officer, Sorcero

Dipanwita Das is the Chief Executive Officer and Co-Founder of Sorcero, a leading platform for advanced analytics and AI in the life sciences. Sorcero serves 23% of the world’s top life sciences companies with AI powering personalized medicine and medical insights. Dipanwita helped author Sorcero's 6 biomedical AI patents powering life sciences products in partnership with Google and Springer Nature. 

Dipanwita previously built the digital scientific platform for the largest global public health policy initiative, influencing health outcomes for over three billion people. Dipanwita completed Stanford GSB’s executive program for social entrepreneurship, earned her master’s degree from IDS at the University of Sussex, and a bachelor’s degree from St. Stephen’s College.

 

29. Mary Lou Jepsen
CEO and Founder, Openwater

Dr. Mary Lou Jepsen is the Chief Executive Officer and Founder of Openwater, an open-source medical technology company focused on diagnostics and therapeutics with a pan-disease R&D platform that spans cancer, mental health, and cardiovascular diseases. She holds over 250 patents and has been a leader in the field of medical technology innovation.

Previously, Dr. Jepsen served as Executive Director of Engineering at Facebook and Oculus, and held a similar role at Google. Prior to these positions, she was a professor at MIT and co-founded the nonprofit organization One Laptop per Child, where she served as CTO and architect of the $100 laptop. Dr. Jepsen also serves on the Board of Directors for Lear Corporation, a Fortune 150 automotive components supplier, and Luminar Technologies, a leader in LiDAR and autonomous driving.

Mary Lou Jepsen's Insight

“The FDA Isn’t Blocking Medical Breakthroughs — Our Outdated Innovation Model Is The current model of siloed, proprietary development is failing us. It's slow, expensive, and often results in technologies that never see the light of day. What if, instead, we embraced an open-source approach to medical device innovation. We can make healthcare better, faster and cheaper. That's the charge we are leading at Openwater.”

 

30. Joy Liu
CEO & Founder, Plenful

Joy Liu is the CEO and Founder of Plenful, an early-stage, high-growth company transforming complex healthcare operations with AI-powered automation. Drawing from her firsthand experience as a health system specialty care and pharmacy operator, Joy witnessed the overwhelming burden of manual, business-critical administrative work that hindered patient care and contributed to staff burnout, becoming the catalyst for creating Plenful’s innovative platform.

Plenful empowers healthcare organizations to scale operations with speed and precision while delivering quality patient care. Joy’s vision is to transform complex healthcare workflows through Plenful’s end-to-end platform, eliminating inefficiencies, enhancing compliance, and driving better margins. Trusted by leading providers, pharmacies, health systems, and payers, Plenful powers smarter, faster, and more cost-effective healthcare operations. By automating the manual work behind healthcare systems, Plenful frees their clients to deliver a quality patient care experience. 

Before founding Plenful, Joy served as an early leader at Shields Health Solutions and began her career at Goldman Sachs. She graduated from Northwestern University.

 

31. John Baird
Chairman, Co-Founder, and Chief Strategy Officer, Vouched

John Baird is the Chairman, Co-Founder, and Chief Strategy Officer of Vouched, a company focused on innovative identity verification solutions. With a background in solving critical challenges across industries, including e-commerce and healthcare, Baird has been instrumental in the development of AI-powered technology for secure identity verification, particularly in sectors like healthcare and automotive.

Under his leadership, Vouched has developed solutions that balance rigorous compliance standards with user-friendly experiences, ensuring accessibility while maintaining high security protocols. Baird’s strategic vision and commitment to AI development continue to push the boundaries of identity verification, driving the creation of more secure, efficient, and inclusive digital infrastructures.

 

32. Sungwon Lim
Co-Founder and Chief Executive Officer, ImpriMed

Dr. Sungwon Lim is the Co-Founder and Chief Executive Officer of ImpriMed, a leading precision medicine startup focused on leveraging artificial intelligence to improve cancer treatment. ImpriMed’s pioneering drug response prediction technology, initially developed for the veterinary oncology market, improves and accelerates treatment efficacy by empowering clinicians with personalized results for each patient. In 2025, the company aims to expand and commercialize its innovative AI-driven solutions into human healthcare, making precision medicine more accessible and cost-effective at scale.

Dr. Lim has more than 20 years of collective experience in academia and biotech companies. His background in the lengthy process of developing new cancer therapeutics inspired his visionary mission to more effectively target cancer with today’s technology, culminating in ImpriMed’s founding in 2017.

Dr. Lim received his PhD in bioengineering from Stanford University and a master’s degree in translational medicine from the University of California, Berkeley. He has previously presented at the Veterinary Cancer Society, World Veterinary Cancer Congress, and Precision Medicine World Conference. 

 

33. Bhupesh Panwar
Co-Founder & COO, XpertDox

Bhupesh Panwar is the Co-Founder and Chief Operating Officer of XpertDox, which he co-founded in 2015. Dr. Panwar is a physician-scientist with expertise in clinical trials, population health, and data analytics. His work has been supported by grant funding from organizations such as the NIH and the American Heart Association.

Dr. Panwar has leveraged big data, artificial intelligence (AI), and natural language processing (NLP) in developing XpertDox's flagship product, XpertCoding. This AI-powered platform automates medical coding and improves clinical documentation, streamlining healthcare operations. By automating over 90% of the coding process, XpertCoding reduces administrative workloads, enhances accuracy, ensures compliance, and accelerates the revenue cycle.

Under Dr. Panwar's leadership, XpertDox has achieved significant technological breakthroughs and widespread adoption across healthcare institutions, revenue cycle organizations, and health-tech companies. 

Bhupesh Panwar's Insight 

"As an entrepreneur, I've always been driven by the potential of technology to solve critical challenges in healthcare. When we founded XpertDox in 2015, we began with a focus on clinical trials, leveraging big data, machine learning, and natural language processing to streamline patient recruitment and improve trial outcomes. However, as we evolved, we saw an even greater opportunity to address the administrative complexities in healthcare. 

With XpertCoding, we've excelled and redefined what's possible in medical coding and documentation. By leveraging big data and integrating NLP with automation, we've created a platform that reduces administrative burdens, improves coding accuracy, and empowers healthcare and health-tech organizations to deliver better care and services. Our journey from clinical trials to pioneering advancements in AI-driven medical coding reflects our unwavering commitment to innovation and impact." 

 

34. Chris Bahl
President, Chief Executive Officer and Co-Founder, AI Proteins

Chris Bahl is the President, Chief Executive Officer, and Founder of AI Proteins, a Boston-based biotech company focusing on re-imagining protein-based medicines through innovative design and development of miniproteins. Leveraging synthetic biology, robotics and automation, and artificial intelligence, AI Proteins creates miniproteins with ideal therapeutic properties. 

Chris' work focuses on advancing the company's pipeline in oncology and exploring partnerships in other therapeutic areas. Prior to founding AI Proteins, Chris was one of the founding faculty members at the Institute for Protein Innovation in Boston, with co-appointments at Boston Children's Hospital and Harvard Medical School. Chris pioneered the ability to computationally design miniproteins de novo as a postdoctoral fellow with Nobel Laureate David Baker at the Institute for Protein Design in Seattle. 

Chris is dedicated to spreading knowledge in computational protein design through initiatives that he founded such as the Boston Protein Design and Modeling Club and The Latin American Workshop on Artificial Intelligence for Protein Design. Chris sits on the Executive Council of The Protein Society, and he serves as a Scientific Advisor for Applied Photophysics and BioLoomics.

Chris Bahl's Insight

"Our mission is to make as many new drugs as possible, and to get them to the patients who desperately need them as fast as we can."

 

35. Maddison Masaeli
Co-Founder and Chief Executive Officer, Deepcell

Maddison Masaeli is the Co-Founder and Chief Executive Officer of Deepcell. Maddison is a strong believer in the power of engineering to advance the world of life sciences and to accelerate biological discovery. She invented Deepcell’s AI-based single-cell analysis and sorting technology with her postdoctoral advisor Euan Ashley and Mahyar Salek, and spun the company out of Stanford University in 2017. She has a multidisciplinary background with experience in electrical engineering, computer science, and bioengineering. 

Maddison holds a bachelor’s degree in electrical engineering from Sharif University of Technology, as well as a master’s degree in computer science and a PhD in bioengineering from the University of California, Los Angeles. She has published several papers in journals and has co-invented multiple patented technologies.

Maddison Masaeli's Insight

"As an entrepreneur, the greatest privilege is leading a team of brilliant minds united by a common vision—to push the boundaries of what’s possible and create solutions that truly matter in people's lives."

 

36. Arpit Khemka
Co-Founder and Chief Executive Officer, SimpleTherapy

Arpit Khemka is the Co-Founder and Chief Executive Officer of SimpleTherapy, a pioneer in digital musculoskeletal (MSK) pain recovery and mental health solutions, specifically designed for employers and health plans to provide for their employees and members. By integrating evidence-based exercise therapy with AI technology, the company aims to deliver highly personalized care tailored to each participant's condition, limitations, and therapeutic response.

Khemka brings 19 years of experience to his current role. Before joining SimpleTherapy, Khemka was a technical lead at KPIT Cummins Infosystems Limited. Earlier in his career he worked with Brain Deals as a software engineer. Khemka graduated from Pune University with an undergraduate degree in information technology.

Arpit Khemka's Insight

“At SimpleTherapy, we’re reimagining musculoskeletal care by leveraging technology and AI to drive engagement, simplify access, and deliver better outcomes. My journey began with the realization that compliance in physical therapy was an overlooked yet critical component of care. By combining clinical expertise with innovative algorithms, we’ve built a platform that empowers patients to take control of their recovery, bridging the gap between technology and personal health. As an entrepreneur, I believe the key to building impactful solutions lies in listening to real-world challenges, embracing complexity, and designing systems that adapt to people’s needs.”

 

37. Satish Movva
Founder and Chief Executive Officer, CarePredict

Satish Movva is the Founder and Chief Executive Officer of CarePredict, an AI-powered digital health company focused on elder care utilizing machine learning and deep learning to surface health insights based on the activities and behaviors patterns of seniors.

Satish previously founded ContinuLink to commercialize the first SaaS software for home care and hospice agencies he developed while serving as CIO at Interim Healthcare. Before that, Satish was the founding CIO of Sheridan Healthcare, where he created the first mobile EMR on a Palm Pilot and the first SaaS EMR for Neonatal ICUs. 

Before his service in healthcare, Satish worked with IBM in the insurance, healthcare, and law enforcement segments, holding various positions including network architect, systems management architect, and security sub-system architect in California, Florida, New Zealand, and Scotland.

Satish Movva's Insight

"As an entrepreneur, I’ve learned that the most transformative innovations arise from personal experiences and profound challenges. My journey with CarePredict started as a caregiver for my aging parents, striving to find a solution where none existed. Harnessing AI to predict and prevent health crises has been a deeply fulfilling mission, proving that technology can truly make a difference when it is driven by empathy and purpose." 

 

38. Andreas Persidis
Co-Founder and Chief Executive Officer, Biovista

Andreas Persidis is the Co-Founder and Chief Executive Officer of Biovista, a healthtech company that for the past 20 years has pioneered the use of AI-driven systematic repositioning to uncover unanticipated value in current drugs. As a leader in the design and development of new AI doctrines that focus on “unknown-unknown” scenario building, Dr. Persidis’ work has led to projects with multiple bio/pharma companies, the FDA, Hewlett Packard, patient advocacy groups and others. 

Currently, his leadership in Biovista has led to the company’s first direct to consumer deployment of the AI Health Shield, a service that cross-references all drugs a patient takes for side effects, drug interactions and cautions, and helps explain what a patient on polypharmacy regimens is experiencing. 

Previously, Persidis held positions at Vodafone and Delcam International. He has managed on behalf of the European Commission a roadmap study on systematic innovation, has served as an expert reviewer and evaluator for the European Commission and has advised the Greek and Austrian governments in IT and the life sciences. He has served as the elected President of the Hellenic BioCluster, as a member of the EU HORIZON2020 expert advisory group on “Innovation for SMEs”, and on the expert advisory group to the Greek Secretariat for Research and Technology.

Dr. Persidis has published extensively and is an invited speaker on innovation and export oriented high-tech companies. He holds a PhD in AI from the University of Strathclyde.

 

39. Matthias Hofmann
Co-Founder and Chief Executive Officer, Eyebot

Matthias Hofmann is the Co-Founder and Chief Executive Officer of Eyebot, a company focused on making vision care accessible to everyone. With a mission to improve daily life through innovative solutions, Matthias and his team developed AI-powered vision test kiosks that provide immediate prescriptions at the point of sale, transforming accessibility in vision care.

Under his leadership, Eyebot has created in-house kiosks that deliver quick, efficient vision testing, addressing a critical need in healthcare. Matthias is proud of the progress the company has made and is excited for the future of Eyebot’s impact on the industry.

 

40. Simon Arkell
CEO, Co-Founder and Board Member, Ryght AI

Simon Arkell is the Chief Executive Officer and Co-Founder of Ryght AI, where he has spearheaded the development of innovative AI solutions that are transforming the healthcare industry. Under Simon's leadership, Ryght AI has made significant strides in leveraging AI to improve patient outcomes, reduce costs, and enhance the overall efficiency of the massive and inefficient clinical trial industry.

Arkell has started and exited two healthcare AI companies prior to Ryght AI, Deep Lens and Predixion Software. Simon is also a two time Olympian, having competed for Australia at the 1992 and 1996 Olympic Games in track and field. 

 

41. Daniel Haders
Founder, CEO, Model Medicines

Daniel Haders II is the CEO and Founder of Model Medicines, where he leads business operations and supports scientific, technological, and regulatory initiatives. With 20 years of experience in healthcare as a scientist, entrepreneur, advisor, and investor, he has played a pivotal role in pharmaceutical development.

As a scientist and pharmaceutical development leader, Dr. Haders previously worked with Model Medicines’ current COO, Sean Russell, at the venture-backed biopharma start-up Lux Biosciences. Together, they collaborated to advance Lux’s LX214 program from inception through a successful Phase I clinical program. The formulation underpinning LX214 was recently approved by the FDA under the name CEQUA. Additionally, he played a key role in securing a partnership between biologics-focused start-up QuiO and the global drug delivery leader SHL Group.

Dr. Haders holds a BS from Columbia University in Biomedical Engineering and a Ph.D. from Rutgers University in Biomedical Engineering. He is a US Department of Education, GAANN Fellow in Molecular, Cellular, and Nanosystems Engineering and a National Science Foundation, IGERT Fellow in Integratively Engineered Biointerfaces. Additionally, he was a Recognized Visiting Graduate Student at Oxford University and holds a Certificate in Leadership and Strategy in Pharma and Biotech from Harvard Business School.

Dr. Haders is a Faculty Member and Advisory Committee Member of the UCSD Digital Health Certificate Program and an Advisor to UCSF’s Catalyst Translational Research Office. He has authored two patents and five peer-reviewed manuscripts and has given invited lectures at international conferences and symposia.

Daniel Haders' Insight

“I’m honored to be recognized among such innovative leaders in Healthcare AI. My journey has always been about harnessing data science, biology, and drug development in tandem, to deliver meaningful therapies for patients facing the highest unmet medical needs. At Model Medicines, we believe that by combining cutting-edge technology with a deep commitment to patient impact, we can redefine what’s possible in medicine.”

 

42. Meijie Wang
Co-Founder & CEO, Metanovas Biotech

Meijie Wang is the Co-Founder and Chief Executive Officer of Metanovas Biotech, a leader in the health and beauty industry, recognized for its strategic partnerships with global brands such as L'Oréal, Beiersdorf, Haleon, Takeda, and Unilever. The company specializes in leveraging AI and advanced biotechnology to drive innovation and elevate standards in cosmetics, medical aesthetics, and functional foods.

Wang brings 11 years of experience to his current role and first got his start in 2014 as a Co-Founder at Studio Qfun. From there, he went on to Olympus Corporation of the Americas, before eventually rising to research engineer of AI applications at DawnLight, his most recent position prior to joining Metanovas Biotech. Wang graduated from Tongji University with an undergraduate degree in cross-disciplinary pilot class.

 

43. Pep Gubau
Chief Executive Officer, Chief Technology Officer and Co-Founder, Aizon

Pep Gubau is a seasoned technology leader with extensive experience in software development and biopharma manufacturing. As CEO, CTO, and Co-Founder of Aizon since October 2014, Gubau has been instrumental in improving global health by leveraging AI to enhance drug manufacturing processes, ensuring higher quality production and expedited market delivery. Aizon improves yield, reduces deviations, and ensures product quality in GxP pharmaceutical manufacturing with real-time, practical AI- powered software as a service solution.

Prior to Aizon, Gubau founded and led gnuine, focusing on software development and cloud architecture for critical real-time SaaS platforms, which was later acquired. Before that, Gubau was the CEO, CTO, and Founder of Physis, specializing in mission-critical software development and high-availability architecture for industrial IT infrastructures. 

Gubau holds a degree in economics from Universitat de Barcelona.

 

44. Evan Feinberg
Co-Founder and Chief Executive Officer, Genesis Therapeutics

Evan Feinberg is the Co-Founder and Chief Executive Officer of Genesis Therapeutics. He first joined the company in 2019. Headquartered in Burlingame, CA, with a fully integrated laboratory in San Diego, Genesis Therapeutics is combining AI and biotechnology to develop treatments for patients with severe conditions. The company is using a proprietary generative and predictive AI platform called GEMS (Genesis Exploration of Molecular Space), to accelerate and optimize small molecule drug discovery. 

The GEMS platform integrates deep learning-based predictive models, molecular simulations, and molecular generative AI. GEMS accelerates hit ID through lead optimization and candidate selection by generating promising molecules for synthesis and experimental testing, and iterating this process through multiple cycles of AI-enabled discovery and optimization. It has leveraged GEMS to build an internal pipeline with multiple programs against high-value targets, including data-poor and canonically undruggable targets where GEMS is uniquely advantaged. 

Previously, Feinberg was a deep learning consultant at Merck and before that an algorithm developer at Stanford University. Earlier in his career he worked with Yale University as a research fellow.

Feinberg earned a PhD in biophysics from Stanford University and an undergraduate degree in applied physics from Yale University.

 

45. Chetan Parikh
Founder and Chief Executive Officer, RAAPID INC

Chetan Parikh is the Founder and Chief Executive Officer of RAAPID INC. He first joined the company in 2022. RAAPID is a full-stack, end-to-end risk adjustment platform that delivers guaranteed compliant ROI, reduces costs, improves accuracy, reduces physician abrasion, and mitigates the risk in OIG and RADV audits while running a successful risk adjustment program. It offers audit, retrospective, and prospective risk adjustment solutions by augmenting near-human reasoning with neuro-symbolic AI as an AI assistant to coders and providers.

Parikh is a serial healthcare entrepreneur and has over 15 years of experience in the AI data category. Previously, he was Chief Executive Officer at ezDI.com and before that an application leader at SABIC. Earlier in his career he worked with Madico as a development engineer.

Parikh earned a master’s degree in chemical and plastics engineering from University of Massachusetts Lowell and an undergraduate degree in chemical engineering from L.D. College of Engineering and Dharmsinh Desai University.

 

46. Sasan Amini
Co-Founder and Chief Executive Officer, Clear Labs

Sasan Amini is the Co-Founder and Chief Executive Officer of Clear Labs. He first joined the company in 2014. Clear Labs uses next-generation sequencing (NGS) to simplify complex diagnostics for clinical and applied markets. By creating a fully automated platform that brings together DNA sequencing, robotics and cloud-based analytics, Clear Labs democratizes genomics applications to deliver increased clarity. 

Clear Labs’ turnkey platform accelerates outcomes and improves accuracy—from food-borne pathogens to infectious diseases, including SARS CoV-2. Clear Labs aims to help the world better understand, track and mitigate tomorrow’s novel pathogens.

Previously, Amini was an advisor at Mindfull Investors and before that a research scientist at Illumina. Earlier in his career he worked with Lewis-Sigler Institute for Integrative Genomics as a postdoctoral research associate.

Amini earned his PhD in genomics from Princeton University and holds multiple patents and publications in the field.

 

47. Tzvia Bader
CEO & Co-Founder, Leal Health

Tzvia Bader is the Chief Executive Officer and Co-Founder of Leal Health, an AI-powered decision-making support platform dedicated to expediting access to all available advanced cancer treatment. Working directly with patients, healthcare providers and pharmaceutical companies, Leal Health provides patients with instant access to precise, advanced cancer treatments and empowers the pharmaceutical and biotech industries to develop patient-centric clinical trials and provide real-time analytics and understanding of patient barriers and motivations. 

Bader brings 25 years of experience to her current role and first got her start in 2000 as a director of product at Amdocs. From there, she went on to Frutarom as director of marketing and business development.

Bader graduated from University of Nottingham with a master’s degree in psychology.

 

48. Victor Strecher
Chief Executive Officer, Kumanu

Victor Strecher is the Chief Executive Officer of Kumanu. He first joined the company in 2015. Kumanu helps organizations transform their approach to workforce wellbeing by addressing root causes often missed in traditional programs: the personal, social, and organizational determinants of health. Kumanu is leading the Wellbeing 3.0 movement.

Previously, Strecher was a director for innovation and social entrepreneurship at University of Michigan and before that a Founder at HealthMedia. Earlier in his career he worked with the University of North Carolina at Chapel Hill as an assistant.

Strecher earned a PhD in health behavior from the University of Michigan.

 

49. Dennis Antonelos
Co-Founder and Chief Executive Officer, CoreCare

Dennis Antonelos is the Co-Founder and Chief Executive Officer of CoreCare, a leading AI-powered workflow platform helping post-acute and long-term Care (PALTC) providers achieve operational excellence. Trusted by over 1,000 locations nationwide, CoreCare increases admissions, optimizes reimbursement rates, improves collection metrics, and reduces administrative burdens within one platform. 

At the heart of CoreCare is collaborative revenue management, which brings together essential data and teams on a unified platform. This approach allows employees, regardless of experience level, to contribute effectively from day one and collaborate on important tasks, while providing management with enhanced visibility into performance. CoreCare replaces fragmented systems and spreadsheets with streamlined workflows that drive measurable outcomes. Supported by Y Combinator and used by leading providers, CoreCare aims to redefine team collaboration and set new standards for AI in long-term care.

Prior to founding CoreCare, Antonelos held various positions in companies like Arcus, Drone USA, Xoriant, and Pike Falls Corporation. He has a strong educational background, having attended Y Combinator, Fairfield University, Questrom School of Business at Boston University, and Harvard Business School.

 

50. Laura Li
Founder, Breakthrough Genomics

Laura Li is the Founder of Breakthrough Genomics, a leader in the clinical interpretation of genomic data. The company has developed two proprietary AI-powered bioinformatic platforms and provided a range of tests for rare disease diagnosis and early cancer detection. Breakthrough Genomics also operates a CAP and CLIA-certified advanced clinical laboratory in Southern California where its team of scientists work to refine and develop new life-saving technologies. 

Li brings 13 years of experience to her current role. Before joining Breakthrough Genomics, she was a clinical lab director at Illumina and before that an associate director of genomics lab at Children's Hospital Los Angeles (CHLA). Earlier in her career she worked with University of Southern California as a faculty member.

Li graduated from The Johns Hopkins University School of Medicine with a PhD in molecular biology and genetics.